{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:20:11Z","timestamp":1770754811230,"version":"3.50.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>An association between \u03b2-blocker (BB) therapy and a reduced risk of major cardiac events and mortality in patients undergoing surgery for hip fractures has previously been demonstrated. Furthermore, a relationship between an increased Revised Cardiac Risk Index (RCRI) score and a higher risk of postoperative mortality has also been detected. The purpose of the current study was to investigate the interaction between BB therapy and RCRI in relation to 30-day postoperative mortality in geriatric patients after hip fracture surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>All patients older than 65 years who underwent primary emergency hip fracture surgery in Sweden between January 1, 2008, and December 31, 2017, except for pathological fractures, were included in this retrospective cohort study. Patients were divided into cohorts based on their RCRI score (RCRI 1, 2, 3, and \u22654) and whether they had ongoing BB therapy at the time of admission. A Poisson regression model with robust standard errors of variance was used, while adjusting for confounders, to evaluate the association between BB therapy, RCRI, and 30-day mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>A total of 126,934 cases met the study inclusion criteria. \u03b2-Blocker therapy was associated with a 65% decrease in the risk of 30-day postoperative mortality in the whole study population (adjusted incidence rate ratio [95% confidence interval], 0.35 [0.32\u20130.38]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). The use of BB also resulted in a significant reduction in 30-day postoperative mortality within all RCRI cohorts. However, the most pronounced effect of BB therapy was seen in patients with an RCRI score greater than 0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>\u03b2-Blocker therapy is associated with a reduction in 30-day postoperative mortality, irrespective of RCRI score. Furthermore, patients with an elevated cardiac risk appear to have a greater benefit of BB therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n            <jats:p>Therapeutic\/care management, level II<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000003358","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T15:01:02Z","timestamp":1626102062000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["The interaction between pre-admission \u03b2-blocker therapy, the Revised Cardiac Risk Index, and mortality in geriatric hip fracture patients"],"prefix":"10.1097","volume":"92","author":[{"given":"Ahmad","family":"Mohammad Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecka","family":"Ahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian Peter","family":"Forssten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Wretenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"issue":"9","key":"bib2-20250806","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","article-title":"A systematic review of hip fracture incidence and probability of fracture worldwide","volume":"23","year":"2012","journal-title":"Osteoporos Int"},{"issue":"9823","key":"bib3-20250806","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(12)60518-2","article-title":"Ageing well: a global priority","volume":"379","year":"2012","journal-title":"Lancet"},{"issue":"9920","key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(14)60443-8","article-title":"Population ageing challenges health care in China","volume":"383","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/17453674.2019.1680485","article-title":"Postoperative mortality after a hip fracture over a 15-year period in Denmark: a national register study","volume":"91","year":"2020","journal-title":"Acta Orthop"},{"issue":"10","key":"bib6-20250806","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s00198-017-4153-6","article-title":"Costs of fragility hip fractures globally: a systematic review and meta-regression analysis","volume":"28","year":"2017","journal-title":"Osteoporos Int"},{"issue":"4","key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1302\/0301-620X.100B4.BJJ-2017-0993.R2","article-title":"Mortality and cause of death postoperatively in patients with a hip fracture: a national cohort longitudinal follow-up study","volume":"100-B","year":"2018","journal-title":"Bone Joint J"},{"key":"bib8-20250806","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2474-12-105","article-title":"Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study","volume":"12","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"bib9-20250806","article-title":"A nationwide observational cohort study of the relationship between beta-blockade and survival after hip fracture surgery","year":"2021","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"1","key":"bib10-20250806","doi-asserted-by":"crossref","first-page":"e000630","DOI":"10.1136\/tsaco-2020-000630","article-title":"Factors associated with optimal patient outcomes after operative repair of isolated hip fractures in the elderly","volume":"5","year":"2020","journal-title":"Trauma Surg Acute Care Open"},{"issue":"3","key":"bib11-20250806","first-page":"CD004476","article-title":"Perioperative beta-blockers for preventing surgery-related mortality and morbidity","volume":"3","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"bib12-20250806","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.surg.2005.03.022","article-title":"A meta-analysis of perioperative beta blockade: What is the actual risk reduction?","volume":"138","year":"2005","journal-title":"Surgery"},{"issue":"1","key":"bib13-20250806","doi-asserted-by":"crossref","first-page":"e000533","DOI":"10.1136\/tsaco-2020-000533","article-title":"\u03b2-adrenergic blockade is associated with a reduced risk of 90-day mortality after surgery for hip fractures","volume":"5","year":"2020","journal-title":"Trauma Surg Acute Care Open"},{"issue":"10","key":"bib14-20250806","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00268-019-05058-z","article-title":"The relationship between severe complications, beta-blocker therapy and long-term survival following emergency surgery for colon cancer","volume":"43","year":"2019","journal-title":"World J Surg"},{"issue":"1","key":"bib15-20250806","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/SLA.0000000000002970","article-title":"\u03b2-Blockade in rectal cancer surgery: a simple measure of improving outcomes","volume":"271","year":"2020","journal-title":"Ann Surg"},{"issue":"23","key":"bib16-20250806","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199612053352301","article-title":"Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"issue":"10","key":"bib17-20250806","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.100.10.1043","article-title":"Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery","volume":"100","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"bib18-20250806","first-page":"17","article-title":"Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery","volume":"33","year":"2017","journal-title":"Can J Cardiol"},{"issue":"6","key":"bib19-20250806","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1503\/cmaj.050011","article-title":"Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk","volume":"173","year":"2005","journal-title":"CMAJ"},{"issue":"4","key":"bib20-20250806","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa041895","article-title":"Perioperative beta-blocker therapy and mortality after major noncardiac surgery","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"bib21-20250806","article-title":"The association between the Revised Cardiac Risk Index and short-term mortality after hip fracture surgery","year":"2020","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"5","key":"bib24-20250806","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","year":"1987","journal-title":"J Chronic Dis"},{"issue":"17","key":"bib26-20250806","first-page":"e418","article-title":"ACC\/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery","volume":"116","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"bib27-20250806","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00590-016-1744-4","article-title":"Thirty-day mortality after hip fractures: has anything changed?","volume":"26","year":"2016","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"7","key":"bib28-20250806","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/anae.14225","article-title":"International Fragility Fracture Network Delphi consensus statement on the principles of anaesthesia for patients with hip fracture","volume":"73","year":"2018","journal-title":"Anaesthesia"},{"issue":"1","key":"bib29-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suc.2014.09.002","article-title":"Changing demographics of the American population","volume":"95","year":"2015","journal-title":"Surg Clin North Am"},{"issue":"1","key":"bib31-20250806","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/2151458510378105","article-title":"The 1-year mortality of patients treated in a hip fracture program for elders","volume":"1","year":"2010","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"12","key":"bib32-20250806","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00198-019-05139-8","article-title":"Comorbidity as the dominant predictor of mortality after hip fracture surgeries","volume":"30","year":"2019","journal-title":"Osteoporos Int"},{"issue":"1","key":"bib33-20250806","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00391-018-1382-z","article-title":"Epidemiology of hip fractures: systematic literature review of German data and an overview of the international literature","volume":"52","year":"2019","journal-title":"Z F\u00fcr Gerontol Geriatr"},{"key":"bib34-20250806","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0020-1383(16)30006-7","article-title":"Hip fracture programs: are they effective?","volume":"47","year":"2016","journal-title":"Injury"},{"issue":"10225","key":"bib35-20250806","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(20)30058-1","article-title":"Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial","volume":"395","year":"2020","journal-title":"Lancet"},{"issue":"35","key":"bib36-20250806","article-title":"2014 ESC\/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"issue":"9627","key":"bib37-20250806","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"bib38-20250806","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/rccm.202010-3943ST","article-title":"Informing healthcare decisions with observational research assessing causal Effect. An official American Thoracic Society research statement","volume":"203","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"bib39-20250806","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bja.2018.02.004","article-title":"Beta-blockers in noncardiac surgery: Did observational studies put us back on safe ground?","volume":"121","year":"2018","journal-title":"Br J Anaesth"},{"key":"bib40-20250806","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jclinepi.2020.06.003","article-title":"The Swedish Hip Fracture Register and National Patient Register were valuable for research on hip fractures: comparison of two registers","volume":"125","year":"2020","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:06:50Z","timestamp":1754496410000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000003358","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}